img

Global Rabies Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rabies Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Rabies Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rabies Vaccine market is projected to reach US$ 1229.1 million in 2034, increasing from US$ 931 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2034. Demand from Pre-exposure Prophylaxis and Post-exposure Prophylaxis are the major drivers for the industry.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Segment by Application


Pre-exposure Prophylaxis
Post-exposure Prophylaxis

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rabies Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rabies Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rabies Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rabies Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rabies Vaccine introduction, etc. Rabies Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Rabies Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Rabies Vaccine Market Overview
1.1 Rabies Vaccine Product Overview
1.2 Rabies Vaccine Market Segment by Type
1.2.1 Vero Cell Rabies Vaccine
1.2.2 BHK
1.2.3 Chick Embryo Cell Rabies Vaccine
1.2.4 Others
1.3 Global Rabies Vaccine Market Size by Type
1.3.1 Global Rabies Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Rabies Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Rabies Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Rabies Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Type (2018-2024)
2 Global Rabies Vaccine Market Competition by Company
2.1 Global Top Players by Rabies Vaccine Sales (2018-2024)
2.2 Global Top Players by Rabies Vaccine Revenue (2018-2024)
2.3 Global Top Players by Rabies Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Rabies Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rabies Vaccine Market Competitive Situation and Trends
2.5.1 Rabies Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Rabies Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Rabies Vaccine Market
2.8 Key Manufacturers Rabies Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rabies Vaccine Status and Outlook by Region
3.1 Global Rabies Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Rabies Vaccine Historic Market Size by Region
3.2.1 Global Rabies Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Rabies Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Rabies Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Rabies Vaccine Forecasted Market Size by Region
3.3.1 Global Rabies Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Rabies Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Rabies Vaccine by Application
4.1 Rabies Vaccine Market Segment by Application
4.1.1 Pre-exposure Prophylaxis
4.1.2 Post-exposure Prophylaxis
4.2 Global Rabies Vaccine Market Size by Application
4.2.1 Global Rabies Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Rabies Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Rabies Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Rabies Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Application (2018-2024)
5 North America Rabies Vaccine by Country
5.1 North America Rabies Vaccine Historic Market Size by Country
5.1.1 North America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Rabies Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Rabies Vaccine Sales in Value by Country (2018-2024)
5.2 North America Rabies Vaccine Forecasted Market Size by Country
5.2.1 North America Rabies Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Rabies Vaccine Sales in Value by Country (2024-2034)
6 Europe Rabies Vaccine by Country
6.1 Europe Rabies Vaccine Historic Market Size by Country
6.1.1 Europe Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Rabies Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Rabies Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Rabies Vaccine Forecasted Market Size by Country
6.2.1 Europe Rabies Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Rabies Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Rabies Vaccine by Region
7.1 Asia-Pacific Rabies Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Rabies Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Rabies Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Rabies Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Rabies Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Rabies Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Rabies Vaccine Sales in Value by Region (2024-2034)
8 Latin America Rabies Vaccine by Country
8.1 Latin America Rabies Vaccine Historic Market Size by Country
8.1.1 Latin America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Rabies Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Rabies Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Rabies Vaccine Forecasted Market Size by Country
8.2.1 Latin America Rabies Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Rabies Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Rabies Vaccine by Country
9.1 Middle East and Africa Rabies Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Rabies Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Rabies Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Rabies Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Rabies Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Rabies Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK (Novartis)
10.1.1 GSK (Novartis) Company Information
10.1.2 GSK (Novartis) Introduction and Business Overview
10.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK (Novartis) Rabies Vaccine Products Offered
10.1.5 GSK (Novartis) Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi-Pasteur Rabies Vaccine Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Chengda
10.3.1 Chengda Company Information
10.3.2 Chengda Introduction and Business Overview
10.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Chengda Rabies Vaccine Products Offered
10.3.5 Chengda Recent Development
10.4 Yisheng
10.4.1 Yisheng Company Information
10.4.2 Yisheng Introduction and Business Overview
10.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Yisheng Rabies Vaccine Products Offered
10.4.5 Yisheng Recent Development
10.5 Prcmise
10.5.1 Prcmise Company Information
10.5.2 Prcmise Introduction and Business Overview
10.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Prcmise Rabies Vaccine Products Offered
10.5.5 Prcmise Recent Development
10.6 VACN
10.6.1 VACN Company Information
10.6.2 VACN Introduction and Business Overview
10.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 VACN Rabies Vaccine Products Offered
10.6.5 VACN Recent Development
10.7 Changsheng
10.7.1 Changsheng Company Information
10.7.2 Changsheng Introduction and Business Overview
10.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Changsheng Rabies Vaccine Products Offered
10.7.5 Changsheng Recent Development
10.8 BCHT
10.8.1 BCHT Company Information
10.8.2 BCHT Introduction and Business Overview
10.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 BCHT Rabies Vaccine Products Offered
10.8.5 BCHT Recent Development
10.9 Hissen
10.9.1 Hissen Company Information
10.9.2 Hissen Introduction and Business Overview
10.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Hissen Rabies Vaccine Products Offered
10.9.5 Hissen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rabies Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rabies Vaccine Industrial Chain Analysis
11.4 Rabies Vaccine Market Dynamics
11.4.1 Rabies Vaccine Industry Trends
11.4.2 Rabies Vaccine Market Drivers
11.4.3 Rabies Vaccine Market Challenges
11.4.4 Rabies Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rabies Vaccine Distributors
12.3 Rabies Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Vero Cell Rabies Vaccine
Table 2. Major Company of BHK
Table 3. Major Company of Chick Embryo Cell Rabies Vaccine
Table 4. Major Company of Others
Table 5. Global Rabies Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Rabies Vaccine Sales by Type (2018-2024) & (K Units)
Table 7. Global Rabies Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Rabies Vaccine Sales by Type (2018-2024) & (US& Million)
Table 9. Global Rabies Vaccine Market Share in Value by Type (2018-2024)
Table 10. Global Rabies Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Rabies Vaccine Sales by Type (2024-2034) & (K Units)
Table 12. Global Rabies Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Rabies Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Rabies Vaccine Sales Market Share in Value by Type (2024-2034)
Table 15. Global Rabies Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Rabies Vaccine Sales by Type (2018-2024) & (K Units)
Table 17. North America Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Europe Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Latin America Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Rabies Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Rabies Vaccine Sales by Company (2018-2024) & (K Units)
Table 27. Global Rabies Vaccine Sales Share by Company (2018-2024)
Table 28. Global Rabies Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Rabies Vaccine Revenue Share by Company (2018-2024)
Table 30. Global Market Rabies Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Rabies Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Rabies Vaccine Market
Table 35. Key Manufacturers Rabies Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Rabies Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Rabies Vaccine Sales by Region (2018-2024) & (K Units)
Table 39. Global Rabies Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Rabies Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Rabies Vaccine Sales Market Share in Value by Region (2018-2024)
Table 42. Global Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Rabies Vaccine Sales by Region (2024-2034) & (K Units)
Table 44. Global Rabies Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Rabies Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Rabies Vaccine Sales Market Share in Value by Region (2024-2034)
Table 47. Global Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Rabies Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Rabies Vaccine Sales by Application (2018-2024) & (K Units)
Table 50. Global Rabies Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Rabies Vaccine Sales Market Share in Value by Application (2018-2024)
Table 53. Global Rabies Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Rabies Vaccine Sales by Application (2024-2034) & (K Units)
Table 55. Global Rabies Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Rabies Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Rabies Vaccine Sales Market Share in Value by Application (2024-2034)
Table 58. Global Rabies Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 60. North America Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Europe Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Latin America Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Rabies Vaccine Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Rabies Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 70. North America Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 73. North America Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 74. North America Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 78. Europe Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 82. Europe Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Rabies Vaccine Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Rabies Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Rabies Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Rabies Vaccine Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Rabies Vaccine Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Rabies Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Rabies Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Rabies Vaccine Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Rabies Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Rabies Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Rabies Vaccine Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Rabies Vaccine Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Rabies Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Rabies Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Rabies Vaccine Sales Market Share in Value by Country (2024-2034)
Table 109. GSK (Novartis) Company Information
Table 110. GSK (Novartis) Introduction and Business Overview
Table 111. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. GSK (Novartis) Rabies Vaccine Product
Table 113. GSK (Novartis) Recent Development
Table 114. Sanofi-Pasteur Company Information
Table 115. Sanofi-Pasteur Introduction and Business Overview
Table 116. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sanofi-Pasteur Rabies Vaccine Product
Table 118. Sanofi-Pasteur Recent Development
Table 119. Chengda Company Information
Table 120. Chengda Introduction and Business Overview
Table 121. Chengda Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Chengda Rabies Vaccine Product
Table 123. Chengda Recent Development
Table 124. Yisheng Company Information
Table 125. Yisheng Introduction and Business Overview
Table 126. Yisheng Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Yisheng Rabies Vaccine Product
Table 128. Yisheng Recent Development
Table 129. Prcmise Company Information
Table 130. Prcmise Introduction and Business Overview
Table 131. Prcmise Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Prcmise Rabies Vaccine Product
Table 133. Prcmise Recent Development
Table 134. VACN Company Information
Table 135. VACN Introduction and Business Overview
Table 136. VACN Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. VACN Rabies Vaccine Product
Table 138. VACN Recent Development
Table 139. Changsheng Company Information
Table 140. Changsheng Introduction and Business Overview
Table 141. Changsheng Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Changsheng Rabies Vaccine Product
Table 143. Changsheng Recent Development
Table 144. BCHT Company Information
Table 145. BCHT Introduction and Business Overview
Table 146. BCHT Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. BCHT Rabies Vaccine Product
Table 148. BCHT Recent Development
Table 149. Hissen Company Information
Table 150. Hissen Introduction and Business Overview
Table 151. Hissen Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Hissen Rabies Vaccine Product
Table 153. Hissen Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Rabies Vaccine Market Trends
Table 157. Rabies Vaccine Market Drivers
Table 158. Rabies Vaccine Market Challenges
Table 159. Rabies Vaccine Market Restraints
Table 160. Rabies Vaccine Distributors List
Table 161. Rabies Vaccine Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Vaccine Product Picture
Figure 2. Global Rabies Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Rabies Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Rabies Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Vero Cell Rabies Vaccine
Figure 6. Global Vero Cell Rabies Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of BHK
Figure 8. Global BHK Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Chick Embryo Cell Rabies Vaccine
Figure 10. Global Chick Embryo Cell Rabies Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Rabies Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Rabies Vaccine Sales Market Share by Type in 2022 & 2034
Figure 15. North America Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Rabies Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Rabies Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Vaccine Revenue in 2022
Figure 27. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Pre-exposure Prophylaxis
Figure 29. Global Pre-exposure Prophylaxis Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Post-exposure Prophylaxis
Figure 31. Global Post-exposure Prophylaxis Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Rabies Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Rabies Vaccine Sales Market Share by Application in 2022 & 2034
Figure 34. North America Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Rabies Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Rabies Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Rabies Vaccine Manufacturing Cost Structure
Figure 45. Rabies Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries